Literature DB >> 6759691

Immunology of pyelonephritis in the primate model. V. Effect of superoxide dismutase.

J A Roberts, J K Roth, G Domingue, R W Lewis, B Kaack, G Baskin.   

Abstract

Ascending acute pyelonephritis was produced in monkeys by infusion of bacteria through a ureteral catheter to the point of intrarenal reflux. This led to a significant inflammatory response with death of renal tubular cells in the area of the tubular granulocytes and bacteria. We gave superoxide dismutase, and found that the inflammatory response was decreased and fewer tubular cells were killed. Ultrastructural change was also decreased in tubular cells adjoining phagocytosing neutrophils. This suggests that renal damage following a bacterial infection may be due to the production and release of superoxide into the tubular lumen during phagocytosis. We believe that it is the initial event which may lead to the eventual loss of renal tissue and function called chronic pyelonephritis.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6759691     DOI: 10.1016/s0022-5347(17)53516-8

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  24 in total

1.  Corticosteroids to prevent kidney scarring in children with a febrile urinary tract infection: a randomized trial.

Authors:  Nader Shaikh; Timothy R Shope; Alejandro Hoberman; Gysella B Muniz; Sonika Bhatnagar; Andrew Nowalk; Robert W Hickey; Marian G Michaels; Diana Kearney; Howard E Rockette; Martin Charron; Ruth Lim; Massoud Majd; Eglal Shalaby-Rana; Marcia Kurs-Lasky; Daniel M Cohen; Ellen R Wald; Greg Lockhart; Hans G Pohl; Judith M Martin
Journal:  Pediatr Nephrol       Date:  2020-06-15       Impact factor: 3.714

Review 2.  Urinary tract infections in children.

Authors:  Sherry Sedberry-Ross; Hans G Pohl
Journal:  Curr Urol Rep       Date:  2008-03       Impact factor: 3.092

3.  P-fimbriae vaccines. I. Cross reactive antibodies to heterologous P-fimbriae.

Authors:  M B Kaack; A Pere; T K Korhonen; S B Svenson; J A Roberts
Journal:  Pediatr Nephrol       Date:  1989-10       Impact factor: 3.714

4.  P-fimbriae vaccines. II. Cross reactive protection against pyelonephritis.

Authors:  J A Roberts; M B Kaack; G Baskin; T K Korhonen; S B Svenson; J Winberg
Journal:  Pediatr Nephrol       Date:  1989-10       Impact factor: 3.714

5.  Evaluation of acute pyelonephritis with DMSA scans in children presenting after the age of 5 years.

Authors:  Neamatollah Ataei; Abbas Madani; Reza Habibi; Mosa Khorasani
Journal:  Pediatr Nephrol       Date:  2005-08-05       Impact factor: 3.714

6.  Evaluation of the effects of ozone therapy on Escherichia coli-induced cytitis in rat.

Authors:  C Tasdemir; S Tasdemir; N Vardi; B Ates; Y Onal; S Erdogan; A Yucel; E Aglamis; Y Yakupogullari; R Altıntas; A Karaman
Journal:  Ir J Med Sci       Date:  2013-03-01       Impact factor: 1.568

7.  Extracellular release of reactive oxygen species from human neutrophils upon interaction with Escherichia coli strains causing renal scarring.

Authors:  H Mundi; B Björkstén; C Svanborg; L Ohman; C Dahlgren
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

Review 8.  The small scarred kidney in childhood.

Authors:  R A Risdon
Journal:  Pediatr Nephrol       Date:  1993-08       Impact factor: 3.714

9.  Protective anti-idiotype antibodies in the primate model of pyelonephritis.

Authors:  M B Kaack; L N Martin; S B Svenson; G Baskin; R H Steele; J A Roberts
Journal:  Infect Immun       Date:  1993-06       Impact factor: 3.441

10.  Prevention of renal scarring from pyelonephritis in nonhuman primates by vaccination with a synthetic Escherichia coli serotype O8 oligosaccharide-protein conjugate.

Authors:  J A Roberts; M B Kaack; G Baskin; S B Svenson
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.